Summary

This report studies Rifampin Drugs market rather than API of Rifampin.

Market Analysis and Insights: Global and Japan Rifampin Market
This report focuses on global and Japan Rifampin market.
In 2020, the global Rifampin market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Rifampin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Rifampin Scope and Market Size
Rifampin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Rifampin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Rifampin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Capsule
Injection
Eye Drop

Segment by Application
Tuberculosis
Leprosy
Legionnaire's Disease
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Sanofi
Wellona Pharma
Mylan
Shenyang Tonglian Group
Fresenius Kabi
Avet Pharmaceuticals Inc.
Lannett Company
Lupin Pharmaceutica
Hikma
Shuangding Pharm
Wuhan Wujing
Jiangsu Puhua Kesheng
Chengdu Jinhua (Hongyun)

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Rifampin Product Introduction
1.2 Market by Type
1.2.1 Global Rifampin Market Size Growth Rate by Type
1.2.2 Capsule
1.2.3 Injection
1.2.4 Eye Drop
1.3 Market by Application
1.3.1 Global Rifampin Market Size Growth Rate by Application
1.3.2 Tuberculosis
1.3.3 Leprosy
1.3.4 Legionnaire's Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Rifampin Market Size, Estimates and Forecasts
2.1.1 Global Rifampin Revenue 2016-2027
2.1.2 Global Rifampin Sales 2016-2027
2.2 Global Rifampin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Rifampin Historical Market Size by Region (2016-2021)
2.3.1 Global Rifampin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Rifampin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Rifampin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Rifampin Sales Forecast by Region (2022-2027)
2.4.2 Global Rifampin Revenue Forecast by Region (2022-2027)

3 Global Rifampin Competitor Landscape by Players
3.1 Global Top Rifampin Manufacturers by Sales
3.1.1 Global Rifampin Sales by Manufacturer (2016-2021)
3.1.2 Global Rifampin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Rifampin Manufacturers by Revenue
3.2.1 Key Rifampin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Rifampin Revenue by Manufacturers (2016-2021)
3.2.3 Global Rifampin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Rifampin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Rifampin Revenue in 2020
3.2.6 Global Rifampin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Rifampin Price by Manufacturers
3.4 Global Rifampin Manufacturing Base Distribution, Product Types
3.4.1 Rifampin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rifampin Product Type
3.4.3 Date of International Manufacturers Enter into Rifampin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Rifampin Market Size by Type (2016-2021)
4.1.1 Global Rifampin Sales by Type (2016-2021)
4.1.2 Global Rifampin Revenue by Type (2016-2021)
4.1.3 Rifampin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Rifampin Market Size Forecast by Type (2022-2027)
4.2.1 Global Rifampin Sales Forecast by Type (2022-2027)
4.2.2 Global Rifampin Revenue Forecast by Type (2022-2027)
4.2.3 Rifampin Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Rifampin Market Size by Application (2016-2021)
5.1.1 Global Rifampin Sales by Application (2016-2021)
5.1.2 Global Rifampin Revenue by Application (2016-2021)
5.1.3 Rifampin Price by Application (2016-2021)
5.2 Rifampin Market Size Forecast by Application (2022-2027)
5.2.1 Global Rifampin Sales Forecast by Application (2022-2027)
5.2.2 Global Rifampin Revenue Forecast by Application (2022-2027)
5.2.3 Global Rifampin Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Rifampin Market Size YoY Growth 2016-2027
6.1.1 Japan Rifampin Sales YoY Growth 2016-2027
6.1.2 Japan Rifampin Revenue YoY Growth 2016-2027
6.1.3 Japan Rifampin Market Share in Global Market 2016-2027
6.2 Japan Rifampin Market Size by Players (International and Local Players)
6.2.1 Japan Top Rifampin Players by Sales (2016-2021)
6.2.2 Japan Top Rifampin Players by Revenue (2016-2021)
6.3 Japan Rifampin Historic Market Review by Type (2016-2021)
6.3.1 Japan Rifampin Sales Market Share by Type (2016-2021)
6.3.2 Japan Rifampin Revenue Market Share by Type (2016-2021)
6.3.3 Japan Rifampin Price by Type (2016-2021)
6.4 Japan Rifampin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Rifampin Sales Forecast by Type (2022-2027)
6.4.2 Japan Rifampin Revenue Forecast by Type (2022-2027)
6.4.3 Japan Rifampin Price Forecast by Type (2022-2027)
6.5 Japan Rifampin Historic Market Review by Application (2016-2021)
6.5.1 Japan Rifampin Sales Market Share by Application (2016-2021)
6.5.2 Japan Rifampin Revenue Market Share by Application (2016-2021)
6.5.3 Japan Rifampin Price by Application (2016-2021)
6.6 Japan Rifampin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Rifampin Sales Forecast by Application (2022-2027)
6.6.2 Japan Rifampin Revenue Forecast by Application (2022-2027)
6.6.3 Japan Rifampin Price Forecast by Application (2022-2027)

7 North America
7.1 North America Rifampin Market Size YoY Growth 2016-2027
7.2 North America Rifampin Market Facts & Figures by Country
7.2.1 North America Rifampin Sales by Country (2016-2021)
7.2.2 North America Rifampin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Rifampin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Rifampin Market Facts & Figures by Region
8.2.1 Asia Pacific Rifampin Sales by Region (2016-2021)
8.2.2 Asia Pacific Rifampin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Rifampin Market Size YoY Growth 2016-2027
9.2 Europe Rifampin Market Facts & Figures by Country
9.2.1 Europe Rifampin Sales by Country (2016-2021)
9.2.2 Europe Rifampin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Rifampin Market Size YoY Growth 2016-2027
10.2 Latin America Rifampin Market Facts & Figures by Country
10.2.1 Latin America Rifampin Sales by Country (2016-2021)
10.2.2 Latin America Rifampin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Rifampin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Rifampin Market Facts & Figures by Country
11.2.1 Middle East and Africa Rifampin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Rifampin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Description and Business Overview
12.1.3 Sanofi Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Rifampin Products Offered
12.1.5 Sanofi Recent Development
12.2 Wellona Pharma
12.2.1 Wellona Pharma Corporation Information
12.2.2 Wellona Pharma Description and Business Overview
12.2.3 Wellona Pharma Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Wellona Pharma Rifampin Products Offered
12.2.5 Wellona Pharma Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Description and Business Overview
12.3.3 Mylan Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Rifampin Products Offered
12.3.5 Mylan Recent Development
12.4 Shenyang Tonglian Group
12.4.1 Shenyang Tonglian Group Corporation Information
12.4.2 Shenyang Tonglian Group Description and Business Overview
12.4.3 Shenyang Tonglian Group Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Shenyang Tonglian Group Rifampin Products Offered
12.4.5 Shenyang Tonglian Group Recent Development
12.5 Fresenius Kabi
12.5.1 Fresenius Kabi Corporation Information
12.5.2 Fresenius Kabi Description and Business Overview
12.5.3 Fresenius Kabi Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Fresenius Kabi Rifampin Products Offered
12.5.5 Fresenius Kabi Recent Development
12.6 Avet Pharmaceuticals Inc.
12.6.1 Avet Pharmaceuticals Inc. Corporation Information
12.6.2 Avet Pharmaceuticals Inc. Description and Business Overview
12.6.3 Avet Pharmaceuticals Inc. Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Avet Pharmaceuticals Inc. Rifampin Products Offered
12.6.5 Avet Pharmaceuticals Inc. Recent Development
12.7 Lannett Company
12.7.1 Lannett Company Corporation Information
12.7.2 Lannett Company Description and Business Overview
12.7.3 Lannett Company Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Lannett Company Rifampin Products Offered
12.7.5 Lannett Company Recent Development
12.8 Lupin Pharmaceutica
12.8.1 Lupin Pharmaceutica Corporation Information
12.8.2 Lupin Pharmaceutica Description and Business Overview
12.8.3 Lupin Pharmaceutica Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Lupin Pharmaceutica Rifampin Products Offered
12.8.5 Lupin Pharmaceutica Recent Development
12.9 Hikma
12.9.1 Hikma Corporation Information
12.9.2 Hikma Description and Business Overview
12.9.3 Hikma Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hikma Rifampin Products Offered
12.9.5 Hikma Recent Development
12.10 Shuangding Pharm
12.10.1 Shuangding Pharm Corporation Information
12.10.2 Shuangding Pharm Description and Business Overview
12.10.3 Shuangding Pharm Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Shuangding Pharm Rifampin Products Offered
12.10.5 Shuangding Pharm Recent Development
12.11 Sanofi
12.11.1 Sanofi Corporation Information
12.11.2 Sanofi Description and Business Overview
12.11.3 Sanofi Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sanofi Rifampin Products Offered
12.11.5 Sanofi Recent Development
12.12 Jiangsu Puhua Kesheng
12.12.1 Jiangsu Puhua Kesheng Corporation Information
12.12.2 Jiangsu Puhua Kesheng Description and Business Overview
12.12.3 Jiangsu Puhua Kesheng Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Jiangsu Puhua Kesheng Products Offered
12.12.5 Jiangsu Puhua Kesheng Recent Development
12.13 Chengdu Jinhua (Hongyun)
12.13.1 Chengdu Jinhua (Hongyun) Corporation Information
12.13.2 Chengdu Jinhua (Hongyun) Description and Business Overview
12.13.3 Chengdu Jinhua (Hongyun) Rifampin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Chengdu Jinhua (Hongyun) Products Offered
12.13.5 Chengdu Jinhua (Hongyun) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Rifampin Industry Trends
13.2 Rifampin Market Drivers
13.3 Rifampin Market Challenges
13.4 Rifampin Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rifampin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer